Phase IV Study of Optimal Stenting Strategy For True Bifurcation Lesions
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 420
- 试验地点
- 12
- 主要终点
- Angiographic binary restenosis rate (diameter stenosis >= 50%) at 8 months in either main or side branch
研究概览
简要总结
It is unclear which stenting strategy will be optimal for true bifurcation coronary lesions.
详细描述
The outcome of percutaneous coronary intervention of bifurcation lesions with bare-metal stents is hindered by increased rates of procedural complications and long-term major adverse cardiac events compared with non-bifurcated lesions.1 Randomized studies have demonstrated that drug-eluting stents reduce restenosis when used in relatively simple lesions; and recent data have demonstrated efficacy of the sirolimus-eluting stent for bifurcation lesions compared with historical data of BMS. In one study of bifurcation lesions, the overall restenosis rate was 23%, with the majority of side branch restenoses occurring at the ostium after use of a T-stenting technique. Indeed, side branch restenosis occurred in 16.7% after T-stenting, compared with 7.1% after other stenting techniques.
The "crush" technique of bifurcation stenting with DESs was introduced by Colombo et al. in 2003 as a relatively simple technique that ensures complete coverage of the side branch ostium, thereby facilitating drug delivery at this site. Initial data of 20 patients treated with this technique with SES suggest that it is a safe method, with an acceptable rate of procedural complications and no further adverse events up to 30 days follow-up. Recently, angiographic data have shown the importance of simultaneous kissing balloon post-dilation in reducing restenosis and need for target lesion revascularization. They also reported that compared to T-stenting, crushing with final kissing balloon dilatation was associated with lower rate of restenosis and target lesion revascularization. Consequently, the crushing is currently most promising technique in treating bifurcation lesions using two stents. However, despite the advance of bifurcation stenting technique, the superiority of bifurcation stenting with crushing technique over simple stenting in bifurcation lesion has not been demonstrated.
Therefore, we conducted the prospective randomized study comparing crushing technique with final kissing balloon dilatation and a simple technique (main vessel stenting and provisional T-stenting) for treatment of true bifurcation lesions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with angina and documented ischemia or patients with documented silent ischemia
- •Patients who are eligible for intracoronary stenting
- •Age >18 years, <75 ages
- •Angiographic
- •De novo lesion located in a major bifurcation point with the MEDINA classification type 1.1.0, 1.0.0, or 0.1.0
- •Main vessel : >= 2.5 mm in vessel size, >= 50% in diameter stenosis and =< 50 mm in lesion length by visual estimation, in which the lesion seems to be covered with =< 2 stents
- •Side branch : >= 2.0 mm in vessel size, >= 50% in diameter stenosis, and < 20 mm in lesion length by visual estimation, in which the lesion seems to be covered with single stent
排除标准
- •History of bleeding diathesis or coagulopathy
- •Known hypersensitivity or contra-indication to contrast agent, heparin, sirolimus and paclitaxel
- •Limited life-expectancy (less than 1 year) due to combined serious disease
- •ST-elevation acute myocardial infarction < 2 weeks
- •Characteristics of lesion:
- •Left main disease
- •In-stent restenosis
- •Graft vessels
- •Chronic total occlusion
- •TIMI flow =< grade 2 in the side branch
- •Renal dysfunction, creatinine >= 2.0mg/dL
- •Contraindication to aspirin, clopidogrel or cilostazol
- •LV ejection fraction =< 35%
结局指标
主要结局
Angiographic binary restenosis rate (diameter stenosis >= 50%) at 8 months in either main or side branch
时间窗: 8 months
次要结局
- Influence of bifurcation angle(8 months)
- Amount of contrast agent(baseline)
- FFR assessment in the side branch(baseline and 8 months)
- Influence of new three segment bifurcation QCA software(8 months)
- Fluoroscopic time(baseline)
- Procedure time(baseline)
- Reocclusion rate at the side branch at 8 month angiographic follow-up(8 months)
- Restenosis rate at the main vessel and/or side branch(8 months)
- Number of used stents(baseline)
- Composite of major cardiac adverse events (MACE) including death, MI, stent thrombosis and ischemia-driven target vessel revascularization(2 years)
- Late loss at the main vessel and the side branch(8 months)
研究者
Seung-Jung Park
MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine
CardioVascular Research Foundation, Korea
